Relative Aggrecan mRNA expression levels, as measured by qPCR, in lentiviral-transduced control cells and 5 AggKD cell lines confirm decreased Aggrecan expression in the AggKD cell... by Juanita K. Hodax (6848540)

Apoptosis inhibitor prevented the decrease of IIL ESP-induced TJs expression and alleviated barrier disruption of Caco-2 monolayer. by Qi Qi Lu (17721401)

Cardamonin induced apoptosis and decreased the MMP of ovarian cancer cells. by Peiguang Niu (17044532)

The success rate for blood lipid goals achievement, including TG<150 mg/dl, TC<200 mg/dl, LDL-C<70 mg/dl, and non-HDL-C<130 mg/dl. by Amirhossein Yadegar (13922190)

Fig 5 - by Dalia Zaafar (6693017)

Combination treatment induced more cell death and decreased cell survival markers more than did single treatments. by Panchanan Maiti (1459852)

Proteosomal and pan-caspase inhibitors differentially prevent the disruption of the epithelial cell barrier by the clinical <i>Leptospira</i> isolates. by Tetsuya Kakita (4922584)

Immunofluorescence analysis using dual staining for E-cadherin (E-cad) and afadin and F-actin in RPTECs infected with Oki53 and Oki65 at 24 h post-infection. by Tetsuya Kakita (4922584)

Pre-treatment of OJS did not mitigate DRG activation but decreased inflammatory responses in BMDM. by Patrice Cunningham (12914917)

Changes of miR-132-3p in rat peritoneum. by Yangyang Yin (14323701)

Subjects:

Changes of fibrotic proteins in rat peritoneum. by Yangyang Yin (14323701)

Subjects:

Changes of miR-132-3p in peritoneal dialysis patients with different duration. by Yangyang Yin (14323701)

Subjects:

Regulation of TGF-<i>β</i>1 protein expression by MiR-132-3p was verified using WB. by Yangyang Yin (14323701)

Subjects:

Changes of peritoneal structure and function in rats. by Yangyang Yin (14323701)

Subjects:

The effect of MiR-132-3p on protein expression in TGF-<i>β</i>1/Smad2/3 signaling pathway was observed by immunofluorescence. by Yangyang Yin (14323701)

Subjects:

Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”

CONSORT flow diagram. by Judith I. Tsui (5983160)

“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”

Adverse events in placebo arm. by Judith I. Tsui (5983160)

“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”

PI+ CD3+ T cells decrease at day 14 after IR while PI+ CD3- cells decrease at all time points. by Jordan A. Gunning (18143970)